Evaluation of Assays for Measurement of Serum (Anti)oxidants in Hemodialysis Patients
Background. Various biomarkers and assays have been used for assessment of (anti)oxidant status in hemodialysis patients, including those intended for measurement of serum total (anti)oxidants, most often as a part of panel biomarkers. Methods. Serum (anti)oxidant status was measured in 32 chronical...
Main Authors: | Tatjana Ruskovska, Eugene H. J. M. Jansen, Risto Antarorov |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/843157 |
Similar Items
-
Serum Biomarkers of (Anti)Oxidant Status for Epidemiological Studies
by: Eugène Jansen, et al.
Published: (2015-11-01) -
Comparative Analysis of Serum (Anti)oxidative Status Parаmeters in Healthy Persons
by: Tatjana Ruskovska, et al.
Published: (2013-03-01) -
Serum anti-hepatitis B surface antigen in hemodialysis patients
by: Rafieian-Kopaei Mahmoud, et al.
Published: (2012-01-01) -
Serum myokine (myostatin and IGF-1) measurement as predictors in hemodialysis patients
by: Homare Shimohata, et al.
Published: (2019-05-01) -
Significance of serum Myostatin in hemodialysis patients
by: Pasquale Esposito, et al.
Published: (2019-12-01)